Jaffetilchin Investment Partners’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-699
| Closed | -$6.42K | – | 1204 |
|
|
2024
Q3 | $6.42K | Buy |
+699
| New | +$5.79K | ﹤0.01% | 989 |
|
|
2024
Q1 | – | Sell |
-24,040
| Closed | -$518K | – | 393 |
|
|
2023
Q4 | $518K | Sell |
24,040
-3,480
| -13% | -$64.2K | 0.05% | 213 |
|
|
2023
Q3 | $512K | Sell |
27,520
-3,862
| -12% | -$90.2K | 0.06% | 190 |
|
|
2023
Q2 | $795K | Buy |
31,382
+2,277
| +8% | +$57.3K | 0.08% | 141 |
|
|
2023
Q1 | $754K | Buy |
29,105
+1,073
| +4% | +$28.7K | 0.09% | 154 |
|
|
2022
Q4 | $663K | Buy |
28,032
+3,673
| +15% | +$99K | 0.08% | 167 |
|
|
2022
Q3 | $618K | Sell |
24,359
-8,286
| -25% | -$291K | 0.08% | 149 |
|
|
2022
Q2 | $1.08M | Sell |
32,645
-15,431
| -32% | -$655K | 0.13% | 112 |
|
|
2022
Q1 | $1.48M | Buy |
48,076
+22,580
| +89% | +$1.63M | 0.17% | 83 |
|
|
2021
Q4 | $2.34M | Sell |
25,496
-5,317
| -17% | -$636K | 0.22% | 75 |
|
|
2021
Q3 | $3.91M | Sell |
30,813
-26,402
| -46% | -$3.84M | 0.42% | 45 |
|
|
2021
Q2 | $10.4M | Buy |
57,215
+28,330
| +98% | +$4.59M | 0.72% | 27 |
|
|
2021
Q1 | $5.25M | Buy |
28,885
+2,203
| +8% | +$511K | 0.62% | 37 |
|
|
2020
Q4 | $5.33M | Buy |
26,682
+8,899
| +50% | +$1.81M | 0.76% | 26 |
|
|
2020
Q3 | $3.9M | Buy |
17,783
+3,799
| +27% | +$804K | 0.72% | 27 |
|
|
2020
Q2 | $2.67M | Buy |
+13,984
| New | +$2.45M | 0.59% | 28 |
|
|
2019
Q4 | – | Sell |
-7,129
| Closed | -$483K | – | 249 |
|
|
2019
Q3 | $483K | Sell |
7,129
-16,484
| -70% | -$1.08M | 0.12% | 115 |
|
|
2019
Q2 | $1.57M | Buy |
23,613
+3,499
| +17% | +$204K | 0.37% | 46 |
|
|
2019
Q1 | $1.12M | Sell |
20,114
-12,910
| -39% | -$788K | 0.25% | 58 |
|
|
2018
Q4 | $1.64M | Buy |
33,024
+3,562
| +12% | +$218K | 0.41% | 37 |
|
|
2018
Q3 | $2.54M | Sell |
29,462
-3,322
| -10% | -$237K | 0.54% | 32 |
|
|
2018
Q2 | $1.9M | Sell |
32,784
-9,862
| -23% | -$482K | 0.42% | 35 |
|
|
2018
Q1 | $1.72M | Buy |
42,646
+17,963
| +73% | +$678K | 0.39% | 39 |
|
|
2017
Q4 | $860K | Sell |
24,683
-19,437
| -44% | -$645K | 0.29% | 67 |
|
|
2017
Q3 | $1.46M | Buy |
44,120
+16,563
| +60% | +$543K | 0.34% | 45 |
|
|
2017
Q2 | $956K | Sell |
27,557
-17,668
| -39% | -$515K | 0.32% | 56 |
|
|
2017
Q1 | $1.13M | Buy |
45,225
+814
| +2% | +$16.9K | 0.29% | 57 |
|
|
2016
Q4 | $733K | Sell |
44,411
-1,757
| -4% | -$29.8K | 0.22% | 76 |
|
|
2016
Q3 | $845K | Buy |
46,168
+4,557
| +11% | +$79.9K | 0.27% | 56 |
|
|
2016
Q2 | $667K | Buy |
+41,611
| New | +$485K | 0.2% | 81 |
|
Other funds holding TDOC
MRCP
Jaffetilchin Investment Partners's TDOC Position: Q4 2024 in Review
Jaffetilchin Investment Partners sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 699 shares — an estimated $6.42K sold.
Jaffetilchin Investment Partners first reported a position in TDOC in Q2 2016 and held it in 30 quarters. The position peaked at $10.4M in Q2 2021. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.
- Jaffetilchin Investment Partners reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
- Jaffetilchin Investment Partners sold 699 Teladoc Health shares in Q4 2024, an estimated $6.42K.
- Jaffetilchin Investment Partners first reported a position in Teladoc Health in Q2 2016 and held it in 30 quarters.
- Jaffetilchin Investment Partners's Teladoc Health position peaked at $10.4M in Q2 2021.
- 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.
Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.